{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:48:57Z","timestamp":1789858137040,"version":"4.0.1"},"reference-count":14,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2016,3,9]]},"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine cancer incidence in a large clinical juvenile-onset arthritis population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We combined data from 6 existing North American juvenile-onset arthritis cohorts. Patients with juvenile-onset arthritis were linked to regional cancer registries to detect incident cancers after cohort entry, defined as first date seen in the paediatric rheumatology clinic. The expected number of malignancies was obtained by multiplying the person-years observed (defined from cohort entry to end of follow-up) by the geographically matched age, sex and calendar year-specific cancer rates. The standardised incidence ratios (SIR; ratio of cancers observed to expected) were generated, with 95% CIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 6 juvenile arthritis registries provided a total of 5294 patients. The mean age at cohort entry was 8.9 (SD 5.0) years and 68% of participants were female. The mean duration of follow-up was 6.8\u2005years with a total of 36\u2005063 person-years spanning 1978\u20132012. During follow-up, 9 invasive cancers occurred, compared with 10.9 expected (SIR 0.82, 95% CI 0.38 to 1.5). 3 of these were haematological (Hodgkin's, non-Hodgkin's lymphoma and leukaemia). 6 of the patients with cancer were exposed to disease-modifying drugs; 5 of these had also been exposed to biological agents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We did not clearly demonstrate an increase in overall malignancy risk in patients with juvenile-onset arthritis followed for an average of almost 7\u2005years. 3 of the 9 observed cancers were haematological. 5 of the cancers arose in children exposed to biological agents. Longer follow-up of this population is warranted, with further study of drug effects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2015-000212","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T22:23:59Z","timestamp":1462314239000},"page":"e000212","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Malignancy incidence in 5294 patients with juvenile arthritis"],"prefix":"10.1136","volume":"2","author":[{"given":"Omid","family":"Zahedi Niaki","sequence":"first","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Ramsey-Goldman","sequence":"additional","affiliation":[{"name":"Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae","family":"Yeung","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hayward","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Seattle Children's Hospital, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiem","family":"Oen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciar\u00e1n M","family":"Duffy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Royal University Hospital, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"O'Neil","sequence":"additional","affiliation":[{"name":"Division of Pediatric Rheumatology, Riley Hospital for Children, Indianapolis, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"von Scheven","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheum San Francisco, University of California, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schanberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Labrecque","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley M L","family":"Tse","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Hasija","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L F","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"key":"2025090313453836000_2.1.e000212.1","doi-asserted-by":"crossref","unstructured":"Lovell DJ . Juvenile idiopathic arthritis: clinical features. In: Kippel JH , Stone JH , Crofford LJ , White PH , eds. Primer on the rheumatic diseases. 13th edn. New York: Springer Science, 2008:142\u20135.","DOI":"10.1007\/978-0-387-68566-3_7"},{"key":"2025090313453836000_2.1.e000212.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.34348"},{"key":"2025090313453836000_2.1.e000212.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.22056"},{"key":"2025090313453836000_2.1.e000212.4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/acr.21709","article-title":"Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents","volume":"64","author":"Nordstrom","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313453836000_2.1.e000212.5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/1471-2407-14-634","article-title":"Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis","volume":"14","author":"Kok","year":"2014","journal-title":"BMC Cancer"},{"key":"2025090313453836000_2.1.e000212.6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J"},{"key":"2025090313453836000_2.1.e000212.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.27741"},{"key":"2025090313453836000_2.1.e000212.8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-432"},{"key":"2025090313453836000_2.1.e000212.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.27511"},{"key":"2025090313453836000_2.1.e000212.10","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-8-18"},{"key":"2025090313453836000_2.1.e000212.11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1546-0096-11-35","article-title":"Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports","volume":"11","author":"Hooper","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"2025090313453836000_2.1.e000212.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675"},{"key":"2025090313453836000_2.1.e000212.13","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20218"},{"key":"2025090313453836000_2.1.e000212.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100711"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2015-000212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:45:46Z","timestamp":1756932346000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2015-000212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,3]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1136\/rmdopen-2015-000212"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2015-000212","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}